Our study firstly illustrated the relationships of expression levels, genetic or epigenetic alterations of SLC3A2 with prognoses, drug response, clinicopathological characteristics, immune cell infiltration, enrichment analysis, and single cell sequencing in BC using online databases. Here, SLC3A2 is linked to breast cancer.